RTOG 1010 - A Phase III Trial Evaluating the Addition of Trastuzumab to TrimodalityTreatment of HER2-Overexpressing Esophageal Adenocarcinoma.
RTOG 0920 – A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer.
© 2018 Berkshire Health Systems
725 North Street
Pittsfield, MA 01201
